Table 1 Details on the included studies in the meta-analysis
Author | Year of publication | Follow-up time (months) | Sample size | Patient mean age (years) | Sex | Bisphosphonates/control group | Intervention protocol |
|---|---|---|---|---|---|---|---|
Hennigs T | 2002 | 12 | 66 | 51.5 | 29/27 | 42/24 | Subgroup 1: oral alendronate 10 mg/day for 10 weeks |
Subgroup 2: oral alendronate 20 mg/day for 5 weeks | |||||||
Arabmotlagh M | 2006 | 72 | 51 | 62.5 | 26/25 | 27/24 | Subgroup 1: oral alendronate 20 mg/day for 2 months, thereafter 20 mg/day for 4 months |
Subgroup 2: oral alendronate 20 mg/day for 2 months, thereafter 20 mg/day for 6 months | |||||||
Arabmotlagh M | 2009 | 72 | 49 | 62.5 | 25/24 | 29/20 | Subgroup 1: oral alendronate 10 mg/day for 10 weeks |
Subgroup 2: oral alendronate 20 mg/day for 5 weeks | |||||||
Iwamoto N | 2011 | 12 | 60 | 65 | 14/46 | 20/40 | Oral alendronate 5 mg/day for 48 weeks |
Skoldenberg OG | 2011 | 24 | 73 | 60 | 30/43 | 36/37 | Oral risedronate 35 mg/week for 6 months |
Tapaninen TS | 2010 | 60 | 16 | 61.4 | 7/9 | 7/9 | Oral alendronate 10 mg/day for 6 months |
Trevisan C | 2010 | 12 | 91 | 64.7 | 53/58 | 42/49 | Oral clodronate 100 mg/day for 10 days, thereafter 100 mg/week for 50 weeks |
Venesmaa PK | 2001 | 6 | 13 | 62.62 | 6/7 | 8/5 | Oral alendronate 10 mg/day for 6 months |
Yamaguchi K | 2005 | 12 | 43 | 68.5 | 0/44 | 26/17 | Subgroup 1: oral etidronate 200 mg/day for 2 weeks, followed by 12 weeks of calcium lactate of 500 mg/day, the cycle was repeated four times |
Subgroup 2: oral etidronate 400 mg/day for 2 weeks, followed by 12 weeks of calcium lactate of 500 mg/day, the cycle was repeated four times | |||||||
Yamasaki S | 2007 | 6 | 40 | 66.7 | 4/36 | 19/21 | Oral risedronate 2.5 mg/week for 6 months |